Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)

Marsh K.; Akl E.; Achan J.; Alzahrani M.; Kevin Baird J.; Bousema T.; Gamboa D.; Lacerda M.; Mendis K.; Penny M.; Schapira A.; Sovannaroth S.; Wongsrichanalai C.; Tiffany A.; Li X.; Shutes E.; Schellenberg D.; Alonso P.; Lindblade K.A.
Marsh, Kevin (7201684011); Akl, Elie (6603011139); Achan, Jane (23471656200); Alzahrani, Mohammed (57794260900); Kevin Baird, J. (58995916200); Bousema, Teun (6506709831); Gamboa, Dionicia (20734091100); Lacerda, Marcus (57259514700); Mendis, Kamini (7004958149); Penny, Melissa (24740980300); Schapira, Allan (7102634396); Sovannaroth, Siv (55874133800); Wongsrichanalai, Chansuda (7005248613); Tiffany, Amanda (55828478800); Li, Xiaohong (59075150900); Shutes, Erin (8373997700); Schellenberg, Davi
7201684011; 6603011139; 23471656200; 57794260900; 58995916200; 6506709831; 20734091100; 57259514700; 7004958149; 24740980300; 7102634396; 55874133800; 7005248613; 55828478800; 59075150900; 8373997700; 7003483370; 57912441200; 6603327957
Development of WHO Recommendations for the Final Phase of Elimination and Prevention of Re-Establishment of Malaria
2024
American Journal of Tropical Medicine and Hygiene
110
4
3
10
7
6
Centre for Tropical Medicine and Global Health, University of Oxford, United Kingdom; Department of Internal Medicine, American University of Beirut, Lebanon, Lebanon; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; Malaria Consortium, London, United Kingdom; Public Health Agency, Ministry of Health, Makkah, Saudi Arabia; Oxford University Clinical Research Unit, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Medical Microbiology, Radboud University Medical Center, Radboud, Netherlands; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Tropical Medicine Foundation Dr Heitor Vieira Dourado, Manaus, Brazil; Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland; Bicol University College of Medicine, Legazpi City, Philippines; National Malaria Program, Ministry of Health, Phnom Penh, Cambodia; Independent Consultant, Bangkok, Thailand; Global Malaria Programme, WHO, Geneva, Switzerland
Marsh K., Centre for Tropical Medicine and Global Health, University of Oxford, United Kingdom; Akl E., Department of Internal Medicine, American University of Beirut, Lebanon, Lebanon, Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; Achan J., Malaria Consortium, London, United Kingdom; Alzahrani M., Public Health Agency, Ministry of Health, Makkah, Saudi Arabia; Kevin Baird J., Centre for Tropical Medicine and Global Health, University of Oxford, United Kingdom, Oxford University Clinical Research Unit, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Bousema T., Department of Medical Microbiology, Radboud University Medical Center, Radboud, Netherlands; Gamboa D., Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Lacerda M., Tropical Medicine Foundation Dr Heitor Vieira Dourado, Manaus, Brazil; Mendis K., Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; Penny M., Swiss Tropical and Public Health Institute, Allschwil, Switzerland, University of Basel, Basel, Switzerland; Schapira A., Bicol University College of Medicine, Legazpi City, Philippines; Sovannaroth S., National Malaria Program, Ministry of Health, Phnom Penh, Cambodia; Wongsrichanalai C., Independent Consultant, Bangkok, Thailand; Tiffany A., Global Malaria Programme, WHO, Geneva, Switzerland; Li X., Global Malaria Programme, WHO, Geneva, Switzerland; Shutes E., Global Malaria Programme, WHO, Geneva, Switzerland; Schellenberg D., Global Malaria Programme, WHO, Geneva, Switzerland; Alonso P., Global Malaria Programme, WHO, Geneva, Switzerland; Lindblade K.A., Global Malaria Programme, WHO, Geneva, Switzerland
The WHO recommends that all affected countries work toward the elimination of malaria, even those still experiencing a high burden of disease. However, malaria programs in the final phase of elimination or those working to prevent re-establishment of transmission after elimination could benefit from specific evidence-based recommendations for these settings as part of comprehensive and quality-controlled malaria guidelines. The WHO convened an external guideline development group to formulate recommendations for interventions to reduce or prevent malaria transmission in areas with very low– to low-transmission levels and those that have eliminated malaria. In addition, several interventions that could be deployed in higher burden areas to accelerate elimination, such as mass drug administration, were reviewed. Systematic reviews were conducted that synthesized and evaluated evidence for the benefits and harms of public health interventions and summarized critical contextual factors from a health systems perspective. A total of 12 recommendations were developed, with five related to mass interventions that could be deployed at higher transmission levels and seven that would be most appropriate for programs in areas close to elimination or those working to prevent re-establishment of transmission. Four chemoprevention, two active case detection, and one vector control interventions were positively recommended, whereas two chemoprevention and three active case detection interventions were not recommended by the WHO. None of the recommendations were classified as strong given the limited and low-quality evidence base. Approaches to conducting higher quality research in very low– to low-transmission settings to improve the strength of WHO recommendations are discussed. © 2024 American Society of Tropical Medicine and Hygiene. All rights reserved.
Antimalarials; Chemoprevention; Humans; Malaria; Mass Drug Administration; World Health Organization; antimalarial agent; Article; attitude to health; chemoprophylaxis; consensus development; disease burden; epidemiological surveillance; evidence based medicine; health care; health care planning; health care policy; malaria; malaria control; mass drug administration; practice guideline; public health service; vector control; human; malaria; World Health Organization
Bill and Melinda Gates Foundation, BMGF, (OPP 1209843); Bill and Melinda Gates Foundation, BMGF
Financial support: The WHO received financial support from the Bill & Melinda Gates Foundation (OPP 1209843) for this work.
American Society of Tropical Medicine and Hygiene
00029637
38118172
Article
Q1
1042
3942